Skip to main content

Table 3 Univariate and Multivariable Competing Risks Model for Transplantation in ESRD Patients (n = 109)

From: Evaluation of laboratory values affecting mortality of end-stage renal disease patients: a competing risks approach

Variables

 

Univariate

Multivariable

 

S-HR

(80% HPD Region)

Adjusted S-HR

(90% HPD Region)

Age

 

1 (0.97–1.04)

1 (0.96–1.03)

Ferritin

 

0.999 (0.99–1.001)

 

Creatinine

 

0.98 (0.95–1.04)

 

Cholesterol

 

0.998 (0.99–1.01)

 

Uric Acid

 

1.18 (0.88–1.58)

 

SGOT

 

0.98 (0.92–1.05)

 

SGPT

 

0.98 (0.94–1.003)

 

‌Sodium

 

0.99 (0.98–1.02)

 

‌FBS

 

1.01 (0.99–1.02)

 

Sex

Male

1.94 (0.53–6.89)

2.81 (0.65–11.45)

Hemoglobin

   
 

\(\le\)10

0.98 (0.44–2.24)

 
 

10-12.5

> 12.5

1

0.51 (0.19–1.29)

 

Potassium

   
 

3.5-5

1

--

 

> 5

0.22 (0.1–0.45)*

0.28 (0.1–0.86)**

ALP

   
 

\(\le\)300

1

 
 

> 300

0.8 (0.4–1.64)

 

Calcium

   
 

\(\le\)8.6

2.41 (0.98–7.33)

 
 

8.6–9.5

\(\ge\)9.5

1

1.03 (0.32–3.6)

 

Phosphorus

   
 

\(<\)5

1

--

 

\(\ge\)5

0.33 (0.16–0.72)*

0.59 (0.19–1.71)

iPTH

   
 

\(\le\)150

0.32 (0.13–0.86)

 
 

150–600

1

 
 

> 600

0.57 (0.25–1.5)

 

Albumin

   
 

\(<\)4

1

 
 

\(\ge\)4

0.86 (0.25–2.38)

 
  1. S-HR: Sub-hazard ratio; HPD region: highest posterior density region; SD: Standard deviation; SGOT: serum glutamic-oxaloacetic transaminase; SGPT: serum glutamic-pyruvic transaminase; FBS: fasting blood sugar; ALP: Alkaline Phosphatase; iPTH: intact parathyroid hormone
  2. * Significant at α = 0.2, ** Significant at α = 0.1